jun 7, 2018: 9 a.m. - 10:15 a.m.
Room 255, Level 2
Even if we can’t find wholesale solutions to treating them, drug developers are looking for clues that point to innovative ways to make progress for treating brain diseases with novel approaches.
Session panelists will include leaders from innovative companies who have sought to exploit even the narrowest avenue across a spectrum of brain diseases, including Alzheimer’s disease, major depression, autism and rare genetic neurodegenerative diseases.
Ability Level: All